Archive for November, 2009
- The First Ophthalmic Innovation Summit
- Does a Fatty Diet Put You at Risk for Macular Degeneration?
- Can Microcurrent Stimulation be Used to Treat Macular Degeneration?
- Alcon Acrysof Natural IOL That Filters Blue Light May Prevent Macular Degeneration
- Corneal Transplant for Fuch’s Corneal Dystrophy?
- Using Acuvail After Treatment of AMD
- Zirgan- New Ganciclovir Ointment for HSV Keratitis
- Kenalog of No Benefit to Photodynamic Therapy
- Is Toric IOL the Right Choice?
- Lumigan or Alphagan for Glaucoma in Patient With Dry AMD and Past Cataract Surgery
- Treatment for Cystoid Macular Edema?
- Oraya IRay In-office Stereotactic X-ray Treatment for AMD: A First Report
- Does Photodynamic Therapy Add Anything to Anti-VEGF Treatments?
- Is LASIK Safe for Endothelium?
- Does Minocycline Inhibit Photoreceptor Degeneration?
- NeoVista Rolls Out Novel Treatment for AMD Using Radiation
- CMS Reverses the Reimbursement for AVASTIN
- Is Ranibizumab Superior to Laser for DME?
- Does Cataract Surgery Increase the Risk of Progression of Age-Related Macular Degeneration?
- Femtosecond Laser- the End of Phaco?
- More AAO Highlights: Steroid implants for DME, Gene Therapy for Retinal Dystrophy, and More
- AAO Highlights: Lasers for Cataract Surgery, Laser Vision Correction Trends, and More
- Does LASIK Cause Retinal Detachment?
- Staining ILM With Blood Instead of Dye
- Robotic Surgery Becoming a Reality
- Do Patients with AMD Benefit from Cataract Surgery?
- Lack of Diffusible VEGF Growth Factor Can Cause Retinal Changes Similar to Dry Macular Degeneration
- Ellex Unveils New Diagnostic Ultrasound System at AAO
- Will New “Dual Optic” Accommodating Intraocular Lens Provide Better Outcomes for Cataract Patients?
- Will Femtosecond Laser Technology Revolutionize Cataract Surgery?
- Lux Biosciences’ Voclosporin Phase II/III Results Presented at AAO
- Don’t Be Afraid of AC IOL’s
- Are IOP Spikes Following Avastin Injections Related to Your Compounding Pharmacy?
- NeoVista®, Inc. Completes Enrollment in Pivotal CABERNET™ Study
- MacuSight’s Perceiva May Treat Diabetic Macular Edema and Wet Macular Degeneration
Subscribe for Free!
